ARCHIVES

“I Can’t Permit Destruction of NSABP,” Fisher Writes

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

November 8, 2013

A.D. Little Gets 42.4 Million Contract Award

May 2, 1975

Zerhouni forms steering committee; Olden to retire.

August 1, 2003

DCE Advisors OK Concepts for Registry, Grants In Breast Cancer

June 25, 1993